{
    "organizations": [],
    "uuid": "566a0f50e6b445fef760eee437efdeca1ae67445",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bio-rad-q4-earnings-per-share-232/brief-bio-rad-q4-earnings-per-share-2-32-idUSASB0C7UF",
    "ord_in_thread": 0,
    "title": "BRIEF-Bio-Rad Q4 Earnings Per Share $2.32",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Bio Rad Laboratories Inc:\n* BIO-RAD REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS\n* Q4 EARNINGS PER SHARE $2.32 * Q4 SALES ROSE 8.6 PERCENT TO $620.4 MILLION * ‍FOR FULL YEAR 2018, COMPANY ANTICIPATES CURRENCY NEUTRAL REVENUE GROWTH OF APPROXIMATELY 3.5 PERCENT TO 4.0 PERCENT ​\n* ‍FOR FULL YEAR 2018, ANTICIPATES IMPROVED PROFITABILITY WITH CURRENCY NEUTRAL OPERATING MARGIN TARGET OF 10 PERCENT​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T05:44:00.000+02:00",
    "crawled": "2018-02-28T12:40:35.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "bio",
        "rad",
        "laboratory",
        "inc",
        "report",
        "financial",
        "result",
        "q4",
        "earnings",
        "per",
        "share",
        "q4",
        "sale",
        "rose",
        "percent",
        "million",
        "full",
        "year",
        "company",
        "anticipates",
        "currency",
        "neutral",
        "revenue",
        "growth",
        "approximately",
        "percent",
        "percent",
        "full",
        "year",
        "anticipates",
        "improved",
        "profitability",
        "currency",
        "neutral",
        "operating",
        "margin",
        "target",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}